BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27677261)

  • 1. Hunting for the ultimate liquid cancer biopsy - let the TEP dance begin.
    Feller SM; Lewitzky M
    Cell Commun Signal; 2016 Sep; 14(1):24. PubMed ID: 27677261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Non-Coding RNAs in Head and Neck Cancer: Roles in Diagnosis, Prognosis, and Therapy Monitoring.
    Diez-Fraile A; Ceulaer J; Derpoorter C; Spaas C; Backer T; Lamoral P; Abeloos J; Lammens T
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
    Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
    World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
    Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
    Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer.
    Kishore C; Karunagaran D
    Mol Cell Biochem; 2022 Jun; 477(6):1817-1828. PubMed ID: 35332394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of circulating non-coding RNAs - an update.
    Anfossi S; Babayan A; Pantel K; Calin GA
    Nat Rev Clin Oncol; 2018 Sep; 15(9):541-563. PubMed ID: 29784926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Educated Platelets as a Noninvasive Biomarker Source for Cancer Detection and Progression Monitoring.
    Best MG; Wesseling P; Wurdinger T
    Cancer Res; 2018 Jul; 78(13):3407-3412. PubMed ID: 29921699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
    Ferracin M; Lupini L; Mangolini A; Negrini M
    Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Noncoding RNAs Have a Promising Future Acting as Novel Biomarkers for Colorectal Cancer.
    Wang JJ; Wang X; Song YX; Zhao JH; Sun JX; Shi JX; Wu ZH; Wang ZN
    Dis Markers; 2019; 2019():2587109. PubMed ID: 31275444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsies.
    Lianidou E; Pantel K
    Genes Chromosomes Cancer; 2019 Apr; 58(4):219-232. PubMed ID: 30382599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of core genes in tumor-educated platelets for human gastrointestinal tumor diagnosis using network-based transcriptomic analysis.
    Jiang Y; He J; Wang X; Liu C; Zhou W; Liu D; Guo Z; Liu K
    Platelets; 2023 Dec; 34(1):2212071. PubMed ID: 37212262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating non-coding RNAs as new biomarkers and novel therapeutic targets in colorectal cancer.
    Yang L; Zhang X; Hu G
    Clin Transl Oncol; 2021 Nov; 23(11):2220-2236. PubMed ID: 34275108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs as circulating biomarkers in osteosarcoma patients.
    Botti G; Giordano A; Feroce F; De Chiara AR; Cantile M
    J Cell Physiol; 2019 Nov; 234(11):19249-19255. PubMed ID: 31032924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free circulating epimarks in cancer monitoring.
    Duforestel M; Briand J; Bougras-Cartron G; Heymann D; Frenel JS; Vallette FM; Cartron PF
    Epigenomics; 2020 Jan; 12(2):145-155. PubMed ID: 31916450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
    Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
    Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-educated platelets.
    In 't Veld SGJG; Wurdinger T
    Blood; 2019 May; 133(22):2359-2364. PubMed ID: 30833413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of cell-free lncRNA in serum of cancer patients].
    Kohls K; Schmidt D; Holdenrieder S; Müller SC; Ellinger J
    Urologe A; 2015 Jun; 54(6):819-25. PubMed ID: 25312755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.